Stocktoria

PMV Pharmaceuticals, Inc. PMVP

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2020-09-25

PMV Pharmaceuticals, Inc. statistics & valuation

Market cap$63.5M
P / B0.6×
Return on equity-74.2%
Return on capital-82%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
2019202020212022202320242025
Operating margin (%)
2019202020212022202320242025
Return on equity (%)
-9.60% -18.70% -29.80% -30.60% -33.30% -74.20% 2019202020212022202320242025
Shares outstanding
3.0M 44.8M 45.4M 45.8M 51.4M 51.9M 53.3M 2019202020212022202320242025
Net debt ($)
2019202020212022202320242025
Share buybacks ($)
2019202020212022202320242025
Return on assets (%)
-24.60% -9.40% -17.40% -27.10% -27.30% -30.70% -66.70% 2019202020212022202320242025
Free cash flow margin (%)
2019202020212022202320242025
Debt / equity (×)
2019202020212022202320242025
EPS ($)
-$2.40 -$1.28 -$1.61 -$1.44 -$1.14 -$1.48 2019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Return on assets-66.7%-30.7%-27.3%-27.1%-17.4%-9.4%-24.6%
Return on equity-74.2%-33.3%-30.6%-29.8%-18.7%-9.6%36.0%
Current ratio10.0912.2214.7822.8024.6656.9022.57

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.